Table 1.
TFEB relevant studies in Alzheimer’s disease.
TFEB Signaling mechanism | Tissue | Phenotype | Reference |
---|---|---|---|
Reduced TFEB expression resulted in lysosomal deficits | AD patient lymphocytes and monocytes | [79] | |
Selective nuclear TFEB exclusion | AD patient brain samples | Negative correlation between pathology & nuclear TFEB levels | [129] |
TFEB is retained in cytosol hence lysosomal activity is reduced in AD patient fibroblasts & iPSC-derived human | Double presenilin KO cells, AD patient fibroblasts & iPSC-derived human AD neurons | [80] | |
APOE ɛ4 may compete with TFEB for binding to CLEAR elements in the lysosomal gene promoters & inhibition of the CLEAR network genes | APOE ɛ4/ɛ4 AD patients. | [130] | |
Increased TFEB expression | AD patient fibroblasts carrying the familial presenilin-1 A246E mutation | [131] | |
TFEB levels are unchanged however, upregulation of a subset of CLEAR network genes | presenilin-1 conditional KO mice | [132] | |
Transcriptome upregulation of TFEB targets | 5x-FAD mice | [133] | |
Enhanced levels of TFEB and TFE3 resulted in elevated expression of autophagy target genes | Hippocampus of AD subjects | [77] | |
GSK inhibitor VIII induces TFEB nuclear translocation | reduced APP levels in vitro | [134] | |
CNS delivery of TFEB selectively cleared p-Tau species | rTg4510 mouse tauopathy model | Rescue of behavioral phenotypes, synaptic deficits, & neurodegeneration | [18] |
Neuron specific TFEB overexpression resulted in decline of toxic p-Tau & lipofuscin levels in the cortex and hippocampus | P301S tauopathy mouse model | Improved performance in memory & learning tests | [81] |
Astrocyte-specific delivery of TFEB promoted Aβ uptake & clearance | hippocampus of of APP/PS1 transgenic mice | Reduced Aβ levels & hippocampal plaque load | [19] |
SIRT1 causes the deacetylation of TFEB increased lysosomal biogenesis & microglial degradation of fibrillary Aβ | ex vivo brain slices of APP/PS1 mice | Reduction of amyloid plaque | [135] |
GCN5 causes TFEB acetylation leading to inhibition of autophagy and lysosome biogenesis | hTau Drosophila model | hTau aggregates & neurotoxicity | [136] |
Curcumin analog C1 activated TFEB, increased autophagy and lysosomal activity | 5xFAD, P301S and 3xTg-AD mice | Improved synaptic & cognitive function | [137] |